Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Short stature and Metaphyseal widening; and very common findings: Metaphyseal dysplasia, Platyspondyly, and Antinuclear antibody positivity. 52 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 8 | Rheumatoid arthritis, Excessive inward curve of the lower back (lumbar hyperlordosis), Kyphoscoliosis |
Brain and nerves | 6 | Mild intellectual disability, Spastic diplegia, Global developmental delay |
Blood and immune system | 6 | Cellular immunodeficiency, Combined immunodeficiency, Autoimmune thrombocytopenia |
Skin | 3 | Hypopigmented skin patches on arms, Vitiligo, Systemic lupus erythematosus |
Lungs and breathing | 3 | Pneumonia, Restrictive ventilatory defect, Recurrent respiratory infections |
Kidneys and urinary system | 1 | Tubulointerstitial fibrosis |
Growth and development | 1 | Short stature |
Ears | 1 | Recurrent otitis media |
Lab test results | 1 | Antinuclear antibody positivity |
Hormones | 1 | Hypothyroidism |
ACP5 encodes acid phosphatase 5, tartrate resistant (325 aa). Involved in osteopontin/bone sialoprotein dephosphorylation. Highest expression in Lung (118.6 TPM) and Spleen (51.9 TPM).
Spondyloenchondrodysplasia with immune dysregulation is associated with mutations in the ACP5 gene on chromosome 19.
ACP5 is classified as a druggable target (Druggable Genome and Enzyme categories) with score 2.0.
41 pathogenic variants reported in ACP5 in ClinVar, including hotspot variant LRG_1218p1:p.Gly109Arg (2-star review).
Variant | Significance | Review Stars | Hotspot |
|---|---|---|---|
LRG_1218p1:p.Gly109Arg | Pathogenic/Likely pathogenic | 2 stars | Yes |
Genetic testing for ACP5 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 3 very common features, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Spondyloenchondrodysplasia with immune dysregulation.
11 publications have been identified in PubMed for Spondyloenchondrodysplasia with immune dysregulation. Research spans Case Report / Case Series (45%), Epidemiology / Natural History (18%), and Review / Meta-Analysis (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 45% |
Disease patterns and progression | 2 | 18% |
Research summaries | 1 | 9% |
Clinical study results | 1 | 9% |
Laboratory research | 1 | 9% |
New treatment approaches | 1 | 9% |
Yalçınkaya B (2026). [PMID: 41620075](https://pubmed.ncbi.nlm.nih.gov/41620075/). *Joint Bone Spine*. [Case Report / Case Series]
Li W (2026). [PMID: 42074507](https://pubmed.ncbi.nlm.nih.gov/42074507/). *Genes (Basel)*. [Review / Meta-Analysis]
Mu H (2026). [PMID: 41993173](https://pubmed.ncbi.nlm.nih.gov/41993173/). *Front Immunol*. [Clinical Trial Publication]
Spivak I (2026). [PMID: 41530961](https://pubmed.ncbi.nlm.nih.gov/41530961/). *Lupus*. [Epidemiology / Natural History]
Pekpak Şahinoğlu E (2025). [PMID: 39853520](https://pubmed.ncbi.nlm.nih.gov/39853520/). *Eur J Pediatr*. [Basic Science / Preclinical]
Akalın A (2025). [PMID: 40626694](https://pubmed.ncbi.nlm.nih.gov/40626694/). *Am J Med Genet A*. [Epidemiology / Natural History]
Liu C (2025). [PMID: 40786056](https://pubmed.ncbi.nlm.nih.gov/40786056/). *Front Pharmacol*. [Case Report / Case Series]
Yalçınkaya B (2025). [PMID: 40145172](https://pubmed.ncbi.nlm.nih.gov/40145172/). *J Yeungnam Med Sci*. [Case Report / Case Series]
Pandurangi S (2025). [PMID: 41203937](https://pubmed.ncbi.nlm.nih.gov/41203937/). *J Clin Immunol*. [Gene Therapy / Novel Therapeutics]
Firat Senturk E (2025). [PMID: 39560632](https://pubmed.ncbi.nlm.nih.gov/39560632/). *Lupus*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 5:40 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Spondyloenchondrodysplasia with immune dysregulation